Amcenestrant

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameAmcenestrant
Drug Alias NameSAR-439859SAR439859
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsMetastatic breast cancerBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[38] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiSanofi Us Services IncSanofi-Aventis Recherche & Developpement +[5] 
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A